Dr. Agarwal's Health Care · NSE: AGARWALEYE · BSE: 544350
Q4 FY26 results · Jan–Mar 2026
Dr. Agarwal's Health Care reported revenue from operations of ₹564.11 crore (up 22.6% from Q4 FY25) and net profit of ₹49.96 crore (up 17.4% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 564.11 | 460.22 | +22.6% | 529.86 | +6.5% |
| Other income | 12.58 | 15.43 | −18.5% | 10.54 | +19.4% |
| Total income | 576.69 | 475.65 | +21.2% | 540.40 | +6.7% |
| Profit before tax | 76.62 | 58.52 | +30.9% | 64.76 | +18.3% |
| Net profit for the period | 49.96 | 42.55 | +17.4% | 43.63 | +14.5% |
| Attributable to shareholders of the company | 39.71 | 32.57 | +21.9% | 33.74 | +17.7% |
| EPS, basic (₹) | 1.25 | 1.04 | +20.2% | 1.07 | +16.8% |
| Net margin (%) | 8.9 | 9.2 | 8.2 |
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 347.86 | 281.02 | +23.8% | 334.84 | +3.9% |
| Other income | 6.21 | 26.93 | −76.9% | 7.11 | −12.7% |
| Total income | 354.07 | 307.95 | +15.0% | 341.95 | +3.5% |
| Profit before tax | 18.41 | 34.05 | −45.9% | 20.40 | −9.8% |
| Net profit for the period | 10.60 | 26.51 | −60.0% | 14.06 | −24.6% |
| EPS, basic (₹) | 0.33 | 0.85 | −61.2% | 0.44 | −25.0% |
| Net margin (%) | 3.0 | 9.4 | 4.2 |
Consolidated
- Filed with BSE
- 21 May 2026, 20:15 IST
- Board meeting
- 21 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 21 May 2026, 20:15 IST
- Board meeting
- 21 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE